ArticleBMC genomics2026
Role of MEG3-miRNAs in immune-inflammatory regulation in age-dependent wool follicle remodeling in Tan sheep.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe “nine-curve” crimped wool is a key economic trait of Tan sheep, which peaks at 35 days of age and disappears in adulthood. However, the regulatory mechanisms underlying this age-dependent trait remain unclear. This study aimed to decipher these mechanisms by analyzing the skin of Tan sheep across critical developmental stages.
resultsWe integrated small RNA sequencing, mRNA sequencing, and proteomics, combined with phenotypic observation and histological analysis, to examine the skin tissues of Tan sheep at three critical developmental stages (embryonic day 120, trait initiation stage; 35 days of age, trait peak stage; 24 months of age, trait disappearance stage). Phenotypic and histological results confirmed that this crimped trait depends on medullated fibers derived from primary follicles; with individual aging, the ratio of secondary to primary follicles increases, and primary follicles degenerate in adulthood, ultimately leading to the loss of the crimped trait. Transcriptomic analysis showed that the PD-1/PD-L1 immune checkpoint pathway is the core hub mediating “immune-follicle” crosstalk. Proteomic results revealed a “transcriptional reserve-translational delay” characteristic in keratin genes such as KRT5 and KRT71, confirming that the phenotype at 35 days of age is a continuation of the developmental program initiated at embryonic day 120. Small RNA analysis revealed a "miRNA storm" that peaks at embryonic day 120 (41 miRNAs in total, 40 of which are derived from the MEG3 (GTL2)-miRNA cluster on chromosome 18), and the expression level of this storm gradually decreases with age. Multi-omics integration analysis found that these MEG3-miRNAs can target six key genes (HOXC6, RILPL2, RAB10, ARL1, MX1, and ST7) and are significantly enriched in immune-inflammatory related pathways, suggesting that they may participate in the development and remodeling of wool follicles by regulating immune-inflammatory responses, thereby affecting the formation of the crimped trait.
conclusionsThis study identifies MEG3-miRNAs as key epigenetic regulators of wool crimping and highlights the role of the immune microenvironment in follicle remodeling. We propose that these MEG3-miRNAs likely inhibit immune activation at embryonic day 120 to support primary follicle development, whereas postnatal reduction of these miRNAs relieves immune suppression, triggering overactivation and primary follicle degeneration. This study provides guidance for Tan sheep breeding, reveals conserved epigenetic‒immune synergy in mammalian skin appendages, and offers a model for studying human age-related hair disorders and cross-species age-dependent traits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.